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Summary Following the recent identification of gastric parietal cell carcinoma (Capella et al., 1984), a
histological and clinical review of 125 consecutive cases of gastric cancers treated surgically during a 9-year
period was undertaken. The pathology was reviewed blind and in addition to H & E sections, staining with
Luxol Fast Blue, phosphotungstic acid haematoxylin and E-M studies were performed to identify parietal cell
differentiation. The surgical procedures performed were curative R2 gastrectomy (n=56), palliative resection
(n =30), gastro-enterostomy (n=25) and intubation (n= 14). The 30-day operative mortality was 12/125 (10%O)
overall and 4/56 (7%) in the curative resection group.
Two parietal cell cancers were identified and a further 4 tumours showed areas of parietal cell
differentiation. All occurred in male patients (mean age 55 years, range 43-62). Sixteen patients out of the 56
patients (29%) who underwent curative R2 resection have survived long-term (mean 5.5 years, range 2.5-11):
4/5 mucosal/submucosal cancers (T,NO), 5/29 intestinal cancers (T2NO 2) 2/16 diffuse cancers (T2NA) and
5/6 with parietal cell cancer/differentiation (T2-3NO-2). There were no survivors beyond 14 months in the
patients who were treated by palliative resection, bypass or intubation irrespective of histology.
This study suggests that gastric parietal cell carcinoma carries a good prognosis after curative resection
despite the advanced stage at presentation.
The major determinants of survival after potentially curative
resection for gastric cancer are extent of mural invasion and
the presence of regional node involvement (Kajitani &
Takagi, 1979; Takayoshi et al., 1983; Miwa, 1979; Cuschieri,
1986). Other reported variables which influence the outcome
are the site, type of carcinoma (intestinal or diffuse) and the
degree of differentiation of the tumour. Since the recognition
of the two main types of gastric carcinoma, intestinal and
diffuse (Lauren, 1965), several ultrastructural histochemical
and immunological studies have been reported. These have
variously demonstrated the presence of endocrine cells in
some gastric cancers (Azzopardi & Pollock, 1963), chief cell
differentiation (Yamashiro et al., 1977) and mucous (signet)
cells which are allied histochemically to the pyloric glands
(Sasano et al., 1969). Parietal cell gastric carcinoma was first
described by Capella et al. (1984) in 3 patients and a further
case was reported recently (Gaffney, 1987). This separate
subtype is identified by the presence of polygonal tumour
cells with abundant eosinophilic faintly granular cytoplasm
reactive with Luxol Fast Blue. Ultrastructurally, the tumour
cells contain abundant mitochondria, tubulovesicles and
intracellular canaliculi. The clinical interest in this type of
carcinoma has been aroused by the apparent favourable
prognosis in the four reported cases.
These two reports suggested the present retrospective
study on the incidence of parietal cell carcinoma and its
influence on prognosis in 125 consecutive patients treated by
one surgeon in an Academic Surgical Unit between 1976 and
1985.
Patients and methods
During the period in question a total of 130 patients (87
males, 43 females, age range 33-78, median 67 years) with
endoscopically diagnosed gastric neoplasms underwent surgi-
cal intervention. The histology at the time of operation
showed gastric carcinoma in 125, non-Hodgkin's lymphoma
in 3, and smooth muscle tumours in 2. A preliminary staging
laparotomy was performed in all the patients. The details of
the operative procedure in the patients with gastric cancer
are shown in Table I. The 3 patients with lymphoma were
Correspondence: A. Cuschieri.
Received 7 December 1987; and in revised form, 26 April 1988.
treated by total gastrectomy and a partial gastric resection
was performed in the two patients with smooth muscle
tumours but these patients were excluded from the present
study. A curative R2/3 total gastric resection was defined ill
accordance with the revised rules of the Japanese Research
Society for Gastric Cancer (1981): complete removal ol'
cancer, level of lymph node clearance beyond tier of histo-
logical node involvement, tumour-free proximal and distal
resection margins (histological). The PTNM was used for thc
histological tumour staging. In the present study, the patho-
logy was reviewed without knowledge of details of clinical
outcome using light-microscopic examination of sections cut
from paraffin embedded blocks. In addition to H & E
staining, special stains were performed: alcian blue, PAS with
and without diastase digestion phosphotungstic acid haema-
toxylin (PTAH) and Kluver-Barrera's Luxol Fast Blue.
Transmission electron microscopy was performed in tumours
containing Luxol Fast Blue positive cells. The material was
obtained from paraffin blocks, taken back to water, post-
fixed in 1% osmium tetroxide, dehydrated and embedded in
resin.
The clinical outcome was reviewed by an independent
clinician who was not involved in the management of any of
these patients and was unaware of the reviewed histological
findings.
Results
The 30-day operative mortality is shown in Table I. The
post-operative deaths included one patient with mucosal
cancer and were due to anastomotic breakdown (n =2),
haemorrhage from the splenic artery (n= 1), pulmonary
Table I Details of surgical management in 125 patients with gastric
cancer
Operative
mortalitya
Procedure Total (%)
Curative resection (R2) 56 4 (7)
Palliative resection 30 3 (10)
Gastro-enterostomy 25 2 (8)
Intubation 14 3 (21)
aMortality within 30 days of surgery.
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infection (n =5), pulmonary aspiration (n= 1), pulmonary
embolism (n= 1) and myocardial infarction (n = 1).
None of the patients who underwent palliative resection,
gastro-enterostomy or intubation survived beyond 14
months, the median survival being 7 months in the palliative
resection group and 3 months in the patients treated with
bypass/intubation. Sixteen out of 56 patients (29%) are still
alive, 2.5 to 11 years (mean 5.5 years) after their curative
gastrectomy. The reviewed histology of the curative resection
group and the long-term survivors is shown in Table II.
Two parietal cell carcinomas were identified and a further
4 tumours showed areas of parietal cell differentiation. The
two parietal cell cancers had been previously reported as
intestinal with goblet cell differentiation in one. Three intesti-
nal and one diffuse cancers had areas of parietal cell
differentiation.
The clinical details of these patients five of whom are still
alive (T2N15.5y, T3N1 ly) are shown in Table III. All have
been males. The two patients with uniform parietal cell
tumours were aged 43 and 50 years respectively. The details
of the pathological staging of the tumours of the long-term
surviving patients are shown in Table IV.
The histological studies showed an almost uniform parietal
cell carcinoma in two patients. The findings were similar to
the four reported cases, with tumour having a solid circum-
scribed pattern with fairly cohesive polyhedral or round cells
with prominent nucleoli containing abundant eosinophilic
faintly granular cytoplasm which stained with Luxol Fast
Blue but not PAS (Figures 1 and 2). Mitotic figures were
frequent in one tumour only. The E-M findings observed
Table II Histology of excised tumour in 56 patients treated by a
curative R2 gastrectomy
Long-term
Histology Total survivors
Mucosal/submucosal cancer 5 4
Intestinal ca (T2) 29 5
Diffuse ca (T2) 16 2
Parietal cell ca 2 2
Ca (D or I) and parietal
cell differentiation 4 3
D=Diffuse; I =Intestinal.
Table III Clinical details of patients with parietal cell
carcinoma/differentiation
Patienta Age Primary Survival
R.L. 51 solid, m, pcd alive, 11 y
K.P. 50 solid, c, pcc alive, 5.5y
Mc.W. 61 infilt., cm, pcd alive, 3y
R.E. 43 solid, a, pcc alive, 3y
W.H. 65 infilt., cm, pcd alive, 2.5y
M.J. 62 infilt., cm, pcd dead, 1.5yb
'All males; a =antral, m =middle third, c =proximal third, pcc=
parietal cell carcinoma, pcd =areas of parietal cell differentiation;
b(T3N2 tumour) Widespread dissemination to liver, lungs and skin.
Table IV ptNM staging of gastric cancers from 16 long-term
surviving patients
Histology n Stage
Mucosal/submucosal 4 T1 No(n =4)
Intestinal ca 5 T2NO(n=3)
T2N1 (n=2)
Diffuse signet ca 2 T2N1(n=2)
Parietal cell ca 5 T2NO
T2N1
T3N, (n=2)
T3N2
Figure 1 H & E (x 500) showing parietal cells infiltrating
between normal gastric glands.
Figure 2 Luxol Fast Blue ( x 500). The polygonal positive stain-
ing cells have a granular cytoplasm and prominent nucleoli.
were similar to those previously reported: moderate numbers
of mitochondria, tubulovesicles and intracellular canaliculi
but no secretory granules. Areas of parietal cell differentia-
tion (positive Luxol Fast Blue polygonal or spindle cells)
were found in another 4 tumours.
Discussion
In this retrospective study long-term survival was encoun-
tered only in patients who had undergone a curative gastric
resection as defined by the Japanese Research Society for
Gastric Cancer (1981). Histochemical studies identified 2
circumscribed uniform parietal cell carcinomas and 4 other
tumours with areas of parietal cell differentiation. Five of
these patients are amongst the 16 long-term survivors despite
the advanced nature of the primary and the presence of
histologically proven regional node deposits. All the parietal
cell tumours occurred in middle aged male patients. The
favourable outcome of these tumours observed in the present
study is in accordance with that in the previously reported 4
cases (Capella et al., 1984; Gaffney, 1987) although more
cases need to be identified before definite prognostic asser-
tions can be made. The identification of these tumours
should not pose any problems to a routine hospital patho-
logy laboratory and we recommend that all circumscribed
gastric cancers with round or polygonal cells containing
abundant eosinophilic faintly granular cytoplasm should be
stained with Luxol Fast Blue or PTAH and if found reactive
to this, they should be examined further by electron
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